Certara acquires Pinnacle 21, a leader in pharmaceutical clinical data standards software. Pinnacle 21 software is used to review drugs for compliance with the Clinical Data Exchange Standards Consortium. The deal will be valued at $310 million and is expected to close in early Q4 2021.